Niva Bupa Health Insurance Reports Audited Financials for FY26; EOM Ratio Improves
Niva Bupa Health Insurance's Board approved audited financial results for FY26 and Q4FY26. The company reported an improved Expenses of Management (EOM) ratio of 28.49% for the quarter and 33.70% for the year ended March 31, 2026, adhering to regulatory guidelines. Auditors issued an unmodified opinion on the financial statements.
The announcement relates to the audited financial results, which are a key indicator for investors. The improvement in the EOM ratio and the clean audit report have a moderate positive impact on investor perception.
The company reported improved financial metrics, particularly the Expenses of Management (EOM) ratio, and received an unmodified audit opinion, indicating a positive financial health and operational efficiency.
Niva Bupa Health Insurance Company Limited announced the outcome of its Board Meeting held on May 08, 2026. The Board approved the audited financial statements and results for the financial year ended March 31, 2026, and the quarter and financial year ended March 31, 2026. The company also approved the audited IFRS financial statements for the financial year ended March 31, 2026.
The audited financial results for the quarter and financial year ended March 31, 2026, received an unmodified audit report from joint statutory auditors M/s. S.R. Batliboi & Co. LLP and M/s. Nangia & Co. LLP.
Notably, the Expenses of Management (EOM) ratio for the year to date ended March 31, 2026, was computed at 28.49% (quarterly) and 33.70% (year-to-date) under the 1/n methodology, which is within the prescribed limits. This is a significant improvement from the previous period and reflects the company's efforts to manage expenses effectively. The meeting commenced at 04:15 P.M. (IST) and concluded at 05:00 P.M. (IST).
What to do with a filing like this
Niva Bupa Health Insurance Company Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Niva Bupa Health Insurance Company Limited. Read the original for the full detail.